ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 347 for:    "nutritional support"

A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer (IPTLDAZCAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02598479
Recruitment Status : Withdrawn (The IRB which was overseeing the study stopped overseeing it)
First Posted : November 6, 2015
Last Update Posted : August 28, 2018
Sponsor:
Information provided by (Responsible Party):
Best Answer for Cancer Foundation

Brief Summary:
The IPTLD QoL Broad Study.

Condition or disease Intervention/treatment
Cancer Other: IPTLD and nutrition therapy

Detailed Description:
A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer.

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The IPTLD QoL Broad Study A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer
Study Start Date : November 2015
Actual Primary Completion Date : August 2018
Actual Study Completion Date : August 2018

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
IPTLD and nutrition therapy
Patients presenting to the Arizona Center for Advanced Medicine for the treatment of cancer using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy
Other: IPTLD and nutrition therapy
The measurement of Quality of Life in patients who choose to use Insulin Potentiation Low Dose Therapy and Nutritional Therapy in the treatment of cancer




Primary Outcome Measures :
  1. Improvement in Quality of Life measured by questionnaires [ Time Frame: 5 years ]
    Improvement in Quality of Life using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy for the Treatment of Cancer, as measured by MD Anderson's MDASI questionnaires



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients over the age of 18 who have chosen to receive IPTLD with nutrition therapy
Criteria

Inclusion Criteria:

  • diagnosis of cancer,
  • age older than 18 years,
  • requesting IPTLD and nutrition therapy

Exclusion Criteria:

  • diagnosis other than cancer,
  • age younger than 18 years,
  • requesting conventional chemotherapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02598479


Locations
United States, Arizona
Arizona Center for Advanced Medicine
Scottsdale, Arizona, United States, 85258
Sponsors and Collaborators
Best Answer for Cancer Foundation
Investigators
Principal Investigator: Martha M Grout, MD, MD(H) Arizona Center for Advanced Medicine

Responsible Party: Best Answer for Cancer Foundation
ClinicalTrials.gov Identifier: NCT02598479     History of Changes
Other Study ID Numbers: Protocol V1- 08-12-2015
First Posted: November 6, 2015    Key Record Dates
Last Update Posted: August 28, 2018
Last Verified: August 2018

Keywords provided by Best Answer for Cancer Foundation:
Cancer
Insulin Potentiation Low Dose Chemotherapy
IPT
IPTLD
Nutrition therapy

Additional relevant MeSH terms:
Insulin, Globin Zinc
Insulin
Hypoglycemic Agents
Physiological Effects of Drugs